Interpublic scoops $750m Pfizer media brief

LONDON - Pfizer is set to switch its estimated $750m global media buying business to the Interpublic Group media agencies Initiative and Universal McCann.

The move is likely to follow the completion next month of Johnson & Johnson's acquisition of Pfizer, which owns brands that include Listerine and Nicorette.

J&J executives are already believed to have instigated talks about moving the Pfizer business, which is held by Carat or MindShare in the majority of markets, into the IPG agencies.

The £21m UK business is expected to move into Initiative, the incumbent on J&J. The account is currently held by MindShare.

Recent reports had suggested that J&J was to launch a wider pitch process in the second quarter of next year, with a view to consolidating the business following the acquisition of Pfizer.

However, it is now unclear how the Pfizer/IPG news will affect the plans.

If you have an opinion on this or any other issue raised on Brand Republic, join the debate in the Forum.

Become a member of Campaign from just £51 a quarter

Get the very latest news and insight from Campaign with unrestricted access to campaignlive.co.uk ,plus get exclusive discounts to Campaign events

Become a member

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an alert now

Partner content